Clinical Trials for Nonsecretory Myeloma Patient - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Clinical Trials for the Nonsecretory Myeloma Patient with Dr. Sascha Tuchman

Clinical Trials for the Nonsecretory Myeloma Patient with Dr. Sascha Tuchman image

Clinical Trials for the Nonsecretory Myeloma Patient with Dr. Sascha Tuchman

Webinar
event May 17, 2022 / 07:00PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Are there any clinical trials that are currently open for non-secretory patients? Why aren't they allowed to participate in the majority of clinical trials? Will clinical trial requirements change in the future so that they can start participating?

Schedule & Agenda

Event panelist Audrey Burton-Bethkee
07:00 PM
Introduction
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. Sascha Tuchman
Event panelist Dr. Sascha Tuchman
07:05 PM
Presentation
Dr. Sascha Tuchman
Dr. Tuchman talks about clinical trials for non-secretory myeloma patients.
Event panelist Audience
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Sascha Tuchman, MD
Sascha Tuchman, MD

Dr. Tuchman is a board-certified medical oncologist and divides his time between clinical care and clinical research. He studies and treats all forms of plasma cell disorders but has a special research interest in amyloidosis, and in managing older, frail patients with multiple myeloma. He has years of experience in managing patients and leading research efforts in these disorders, and he directs the multiple myeloma and amyloidosis program at UNC. As part of that role, he mentors the research and career development of trainees who have an interest in myeloma and related conditions. Outside UNC, Dr. Tuchman sits on expert groups that design research in and formulate guidelines for managing plasma cell disorders, such as the International Myeloma Working Group, the International Society for Amyloidosis, and the multiple myeloma committee in the Alliance cooperative cancer research group. When not at work, he enjoys playing ice hockey, cycling, playing music, studying languages, reading history, and spending time with his family including his wife and three sons.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Non-Secretory Myeloma group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.